Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
K.TannerC
Our findings may provide basic theoretical basis and experimental support for the discovery of effective targets or favorable factors for PAAD in clinical treatment and prognosis
As a natural allosteric activator of PKM2, the final enzyme in glycolysis, serine also modulates glycolytic flux [19]
Aranda, S
Enicepatide: Roche's CT-388 Hits 22.5% at ADA 2026 Roche's enicepatide (CT-388) hit 22.5% placebo-adjusted weight loss at ADA 2026
US$ 21.25
US$ 24.58
US$ 29.92
US$ 22.26
US$ 27.94
US$ 26.33
